Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
Asthma & COPD Medications Chart - National Asthma Council Australia
Navigating New Treatment Options for COPD | Consultant360
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Variability of COPD Inhaler Coverage in Medicare Part D
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Scientific Reports
Results for Combo | GrepMed
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic | COPD
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Available iCS plus LABA combination products | Download Table
Chronic obstructive pulmonary disorder (COPD) inhaler criteria - Province of British Columbia
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
Copd antibiotic treatment
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram